Aysegul Yildiz
Mugla, Turkey
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
Investigating the P53-dependent anti-cancer effect of ibutamoren in human cancer cell lines.
Journal: Basic & clinical pharmacology & toxicology
Published: August 23, 2024
The Role of Speedy/RINGO Protein in Breast Cancer as a Future Biomarker.
Journal: Cancer diagnosis & prognosis
Published: January 19, 2024
A potential posttranscriptional regulator for p60-katanin: miR-124-3p.
Journal: Cytoskeleton (Hoboken, N.J.)
Published: March 13, 2023
Current molecular and therapeutic advances in liposarcoma, rhabdomyosarcoma, leiomyosarcoma, synovial sarcoma, and angiosarcoma.
Journal: Journal of oncology pharmacy practice : official publication of the International Society of Oncology Pharmacy Practitioners
Published: January 19, 2022
Speedy/RINGO protein interacts with ERK/MAPK and PI3K/AKT pathways in SH-SY5Y neuroblastoma cells.
Journal: Molecular and cellular biochemistry
Published: May 03, 2020
Salicylidene acylhydrazides attenuate survival of SH-SY5Y neuroblastoma cells through affecting mitotic regulator Speedy/RINGO and ERK/MAPK-PI3K/AKT signaling.
Journal: Medical oncology (Northwood, London, England)
Published: April 14, 2020
p60-katanin: a novel interacting partner for p53.
Journal: Molecular biology reports
Published: April 08, 2020
Effect of the Interaction Between Selenium and Zinc on DNA Repair in Association With Cancer Prevention.
Journal: Journal of cancer prevention
Published: April 24, 2019
Showing 1-8 of 8
Last Updated: 09/26/2026